References in periodicals archive ?
The report reviews pipeline therapeutics for Huntington Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
A case of adult-onset Huntington disease presenting with spasticity and cerebellar ataxia, mimicking spinocerebellar degeneration.
This same molecule has been used in clinical trials for the treatment of Parkinson's and other neurodegenerative diseases, so using this molecule to treat patients with Huntington disease in a small first stage clinical trial could happen relatively quickly.
A predictive testing service for Huntington disease (HD) and late onset spinocerebellar ataxia (SCA1) in Cape Town.
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Our findings allow for the possibility that controlled over-expression of RCAN1-1L might in the future be a viable avenue for therapeutic intervention in Huntington disease patients," said Davies.
Huntington disease in black Zimbabwean families living near the Mozambique border.
NASDAQ: MDVN) today announced the initiation of a Phase 3 trial of the investigational drug dimebon (latrepirdine)* in patients with Huntington disease.
The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe and Australia, experienced in the care of Huntington patients and dedicated to clinical research of Huntington disease.
Stem Cell Innovations is developing a potentially powerful technology that may offer a route to screening for novel treatment alternatives for patients with Huntington disease," said Dr.
chairman of the board of trustees of the Huntington Disease Society of America (HDSA), said, "Patients and families affected by Huntington's disease have become close observers of the science arena looking for hope.

Full browser ?